Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Theranos Founder Holmes, President Balwani Indicted

Published: Fri, 15 Jun 2018 21:22:27 EDT
Theranos Inc founder Elizabeth Holmes and the blood testing company’s former president, Ramesh 'Sunny' Balwani, have been indicted by a federal grand jury in California on charges of wire fraud, the US Justice Department said on Friday.
Reuters Health Information

Investigational Oral Medication Promising for Endometriosis Pain

Published: Fri, 15 Jun 2018 18:05:33 EDT
Investigational oral agent, elagolix, shows promise for the treatment of endometriosis-related pain with good efficacy and safety data now out to 12 months in 2 extension studies; drug is awaiting approval.
Medscape Medical News

NSAIDs Increase Cardiovascular Risk in Osteoarthritis

Published: Fri, 15 Jun 2018 16:46:44 EDT
Nonsteroidal anti-inflammatory drugs contribute to the elevated risk for cardiovascular disease in people with osteoarthritis, new research shows, but alternatives for pain management are limited.
Medscape Medical News

Fourth EAN Meeting Tackles Theme of Neurogenetics

Published: Fri, 15 Jun 2018 16:45:10 EDT
New insights into genetic influences on brain disorders are emerging every day, says the president of the European Academy of Neurology.
Medscape Medical News
Displaying results 17-20 (of 20)
 1 - 2 - 3 - 4 - 5 


BridgeBio spins out ultrarare genetic disease company after acquiring enzyme from Alexion

Published: Mon, 11 Jun 2018 14:58:49 +0000
Through an agreement with Alexion Pharmaceuticals, BridgeBio Pharma acquired a synthetic enzyme replacement therapy for an ultrarare, fatal genetic disease that causes seizures in infants. A new spinout, Origin Biosciences, will handle development.

Soon-Shiong planning to take cancer vaccine subsidiary public: report

Published: Mon, 11 Jun 2018 13:30:24 +0000
Billionaire healthcare mogul Patrick Soon-Shiong hopes to take public later this year one of his companies that is spearheading development of a cocktail of biologics as a vaccine aimed at multiple facets of cancer, according to an interview with Reuters.

Testing for 63 gene variants identifies elevated risk for prostate cancer

Published: Mon, 11 Jun 2018 13:16:21 +0000
A transatlantic team of scientists led by the London-based Institute of Cancer Research has developed a test that can identify men who are six times more likely to develop prostate cancer because of inherited risk. They believe their findings could improve screening, treatment and prevention of the disease.

Alexion snags option to buy neurodegeneration startup Complement

Published: Mon, 11 Jun 2018 13:11:31 +0000
Alexion has secured the option to acquire Dutch biotech Complement Pharma. The agreement will see Alexion work with Complement to take a C6 complement inhibitor through phase 1b and decide whether to pull the trigger on a takeover along the way.
Displaying results 21-24 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy